Genes unique to SCLC-I panel were enriched for lymphocyte activation and proliferation pathways, while the genes unique to SCLC-REST were related to the regulation of the innate immune activation (Fig. 9b). The gene discussed is REST; the disease is small cell lung carcinoma.